Pharmacy Services Provided to Patients with Polycythemia VeraVideo Categories: Pharmacy
Supported through funding from Incyte
The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
Dr Wainberg and Dr Gerson talk about blocking cancer stem cell pathways and how randomized trials using therapies aimed at these pathways.